Pravibismane
Pravibismane (BisEDT; MBN-101) is a broad-spectrum topical anti-infective and anti-biofilm agent. Pravibismane disrupts bacterial bioenergetics by reducing bacterial concentrations of ATP in both planktonic and biofilm phenotypes and exhibits potent anti-biofilm activity against diabetic foot infections (DFI) -relevant pathogens, such as S. aureus and P. aeruginosa. Pravibismane can be used for the study of diabetic foot infections[1].
Product Specifications
CAS Number
[175880-68-9]
Product Name Alternative
BisEDT; MBN-101
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
[Bi]1(SCCS1)SCCS[Bi]2SCCS2
Molecular Formula
C6H12Bi2S6
Molecular Weight
694.51
References & Citations
[1]Lipsky BA, et al. Topical pravibismane as adjunctive therapy for moderate or severe diabetic foot infections: A phase 1b randomized, multicenter, double-blind, placebo-controlled trial. Int Wound J. 2024 Apr;21 (4) :e14817.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15353652 1 Vial
Lentiviral human CTCFL shRNA (UAS) - Lentiviral human CTCFL shRNA (UAS, GFP) (100)
Ask
View Details NBP2-41229PCP 0.1 mL
Rabbit Polyclonal Heartland Virus Glycoprotein 2 Antibody [PerCP]
Ask
View Details